Who is sponsoring NCT05951361?

NCT05951361 is sponsored by Alexandria University.

What drugs are being tested in NCT05951361?

Interventions in NCT05951361: 980nm Diode Laser, 0.1% topical triamcinolone Acetonide preparation "Kenacourt-A Orabase".

What condition does NCT05951361 study?

NCT05951361 studies Erosive Oral Lichen Planus.

Is NCT05951361 still recruiting?

NCT05951361 is currently completed. Last updated 19 July 2023.

Last reviewed 2023-07-19 · How we verify

NCT05951361

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Diode Laser and Topical Steroid Therapy in the Treatment of Erosive Oral Lichen Planus

Completed NA Last updated 19 July 2023

What this trial tests

NA trial testing 980nm Diode Laser in Erosive Oral Lichen Planus in 44 participants. Completed in 10 April 2023.

Timeline

1 February 2022

Primary endpoint
10 February 2023

10 April 2023

Quick facts

Lead sponsor	Alexandria University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	44
Start date	1 February 2022
Primary completion	10 February 2023
Estimated completion	10 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

980nm Diode Laser
0.1% topical triamcinolone Acetonide preparation "Kenacourt-A Orabase" — full drug profile →

Conditions studied

Erosive Oral Lichen Planus — all drugs for Erosive Oral Lichen Planus →

Sponsor

Alexandria University

Who can join

Adults 30 to 70, any sex, with Erosive Oral Lichen Planus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study evaluates the effect of diode laser in treatment of oral lichen planus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Photobiomodulation versus corticosteroid in the management of erosive oral lichen planus: a randomized controlled clinical trial.
Mohamed RK, Elsayed NM, Mahmoud SA, Gaweesh YY. · · 2024 · cited 9× · PMID 38365694 · DOI 10.1186/s12903-024-03976-6

Verify or expand the search:

Other recruiting trials for Erosive Oral Lichen Planus

Currently open trials in the same condition.

NCT06988527 — Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment · Phase 2, PHASE3 · recruiting

Other Alexandria University trials

Trials by the same sponsor.

NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05951361 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandria University
Last refreshed: 19 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05951361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing